Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-06-14 Tx date 2018-06-13 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,455
+79,000 vol $0.145 each |
79,000 | |
Filed 2018-06-14 Tx date 2018-06-14 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,045
+21,000 vol $0.145 each |
100,000 | |
Filed 2018-03-20 Tx date 2016-04-29 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+175,000 vol |
175,000 | |
Filed 2018-03-20 Tx date 2016-04-29 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+175,000 vol |
||
Filed 2018-03-20 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+62,500 vol $0.12 each |
1,539,378 | |
Filed 2018-03-20 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$70,000
+500,000 vol $0.14 each |
1,439,378 | |
Filed 2018-03-20 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+37,500 vol $0.12 each |
1,476,878 | |
Filed 2018-03-20 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$50,000
+500,000 vol $0.10 each |
675,000 | |
Filed 2018-03-16 Tx date 2018-03-16 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,600
-320,000 vol $0.13 each |
||
Filed 2018-03-16 Tx date 2018-03-15 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,570
-89,000 vol $0.13 each |
0 | |
Filed 2018-03-16 Tx date 2018-03-16 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,780
-106,000 vol $0.13 each |
939,378 | |
Filed 2018-03-16 Tx date 2018-03-16 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,600
-320,000 vol $0.13 each |
||
Filed 2018-03-16 Tx date 2018-03-15 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,350
-195,000 vol $0.13 each |
1,045,378 | |
Filed 2018-03-02 Tx date 2018-03-01 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
700,000 | |
Filed 2018-02-27 Tx date 2018-02-27 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
200,000 | |
Filed 2017-12-03 Tx date 2017-12-01 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+25,000 vol $0.13 each |
1,239,878 | |
Filed 2017-12-03 Tx date 2017-12-01 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65.00
+500 vol $0.13 each |
1,240,378 | |
Filed 2017-11-17 Tx date 2017-11-16 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+5,000 vol $0.13 each |
1,214,878 | |
Filed 2017-11-15 Tx date 2017-11-14 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+10,000 vol $0.16 each |
1,185,378 | |
Filed 2017-11-15 Tx date 2017-11-15 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,675
+24,500 vol $0.15 each |
1,209,878 | |
Filed 2017-10-05 Tx date 2017-10-04 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+10,000 vol $0.135 each |
1,175,378 | |
Filed 2017-09-01 Tx date 2017-09-01 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,250
+50,000 vol $0.165 each |
1,165,378 | |
Filed 2017-09-01 Tx date 2017-09-01 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,200
+20,000 vol $0.16 each |
1,115,378 | |
Filed 2017-08-28 Tx date 2017-08-28 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+50,000 vol $0.16 each |
1,095,378 | |
Filed 2017-08-17 Tx date 2017-08-15 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,000
-200,000 vol $0.16 each |
1,045,378 | |
Filed 2017-08-10 Tx date 2017-08-10 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$480.00
+3,000 vol $0.16 each |
1,243,378 | |
Filed 2017-08-10 Tx date 2017-08-10 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$320.00
+2,000 vol $0.16 each |
1,245,378 | |
Filed 2017-08-08 Tx date 2017-08-04 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+10,000 vol $0.16 each |
1,240,378 | |
Filed 2017-08-03 Tx date 2017-08-02 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80.00
+500 vol $0.16 each |
1,228,378 | |
Filed 2017-08-03 Tx date 2017-08-03 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$320.00
+2,000 vol $0.16 each |
1,230,378 | |
Filed 2017-07-28 Tx date 2017-07-27 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$247.50
+1,500 vol $0.165 each |
1,227,878 | |
Filed 2017-07-18 Tx date 2017-07-17 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$247.50
+1,500 vol $0.165 each |
1,226,378 | |
Filed 2017-07-17 Tx date 2017-07-17 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$577.50
+3,500 vol $0.165 each |
1,224,878 | |
Filed 2017-03-15 Tx date 2017-03-15 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,500
+25,000 vol $0.22 each |
1,221,378 | |
Filed 2017-03-09 Tx date 2017-03-09 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,380
+6,000 vol $0.23 each |
1,196,378 | |
Filed 2017-02-28 Tx date 2017-02-28 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,945
-29,000 vol $0.205 each |
1,190,378 | |
Filed 2017-02-28 Tx date 2017-02-28 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,515
-21,000 vol $0.215 each |
1,219,378 | |
Filed 2017-02-17 Tx date 2017-02-17 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+25,000 vol $0.21 each |
1,240,378 | |
Filed 2017-02-10 Tx date 2017-02-09 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,250
+25,000 vol $0.17 each |
1,215,378 | |
Filed 2017-02-07 Tx date 2017-02-07 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$340.00
+2,000 vol $0.17 each |
1,167,378 | |
Filed 2017-02-07 Tx date 2017-02-07 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$680.00
+4,000 vol $0.17 each |
1,190,378 | |
Filed 2017-02-07 Tx date 2017-02-07 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,230
+19,000 vol $0.17 each |
1,186,378 | |
Filed 2017-01-11 Tx date 2017-01-10 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$760.00
+4,000 vol $0.19 each |
1,165,378 | |
Filed 2016-11-22 Tx date 2016-11-18 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150.00
+1,000 vol $0.15 each |
53,000 | |
Filed 2016-11-22 Tx date 2016-11-21 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$320.00
+2,000 vol $0.16 each |
89,000 | |
Filed 2016-11-22 Tx date 2016-11-18 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$797.50
+5,500 vol $0.145 each |
87,000 | |
Filed 2016-11-22 Tx date 2016-11-18 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,974
+55,000 vol $0.145 each |
||
Filed 2016-11-22 Tx date 2016-11-18 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,560
+28,500 vol $0.16 each |
81,500 | |
Filed 2016-08-10 Tx date 2016-08-10 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,925
+13,000 vol $0.225 each |
1,161,378 | |
Filed 2016-08-05 Tx date 2016-08-05 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,075
+5,000 vol $0.215 each |
1,148,378 | |
Filed 2016-08-05 Tx date 2016-08-05 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,505
+7,000 vol $0.215 each |
1,143,378 | |
Filed 2016-04-29 Tx date 2016-04-29 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$140,000
+700,000 vol $0.20 each |
1,136,378 | |
Filed 2016-04-29 Tx date 2016-04-29 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+175,000 vol |
175,000 | |
Filed 2016-04-29 Tx date 2006-07-27 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-04-25 Tx date 2016-04-22 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-140,000
-700,000 vol $0.20 each |
436,378 | |
Filed 2016-01-13 Tx date 2016-01-12 |
$PRK
Potash Ridge Corporation |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+150,000 vol $0.07 each |
3,317,500 | |
Filed 2015-12-03 Tx date 2015-12-01 |
$PRK
Potash Ridge Corporation |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+400,000 vol $0.04 each |
600,000 | |
Filed 2015-11-05 Tx date 2015-11-04 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,000
+200,000 vol $0.255 each |
700,000 | |
Filed 2015-06-30 Tx date 2015-06-30 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+25,000 vol $0.24 each |
1,136,378 | |
Filed 2015-06-11 Tx date 2015-06-10 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+25,000 vol $0.26 each |
1,111,378 | |
Filed 2015-05-08 Tx date 2015-05-06 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,000
+100,000 vol $0.33 each |
1,086,378 | |
Filed 2015-05-05 Tx date 2015-05-04 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,600
-190,000 vol $0.34 each |
987,070 | |
Filed 2015-05-05 Tx date 2015-05-04 |
$BCT
BriaCell Therapeutics Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-231.82
-692 vol $0.335 each |
986,378 | |
Filed 2014-01-24 Tx date 2014-01-24 |
$BCT
Ansell Capital Corp. |
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,430
+98,000 vol $0.035 each |
3,701,166 |